Identification of Genetic Changes in Indian Lung Cancer Patients
Not Applicable
- Conditions
- Health Condition 1: C34- Malignant neoplasm of bronchus andlung
- Registration Number
- CTRI/2019/12/022284
- Lead Sponsor
- DST INSPIRE Fellowship
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients diagnosed with lung cancer
Age less than 75 years and more than 18 years
Patients who are willing to give informed consent
Exclusion Criteria
HIV positive lung cancer patients
Patients with seriously ill conditions and major co-morbidities
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Detection of EGFR T790M mutation in ctDNA using liquid biopsy (CastPCR technology) in lung cancer patients.Timepoint: 3 years
- Secondary Outcome Measures
Name Time Method Demographic characteristics, clinical presentations, Histopathology reports, diagnostic results, Clinical response and survival in different sequence of chemotherapy /EGFR Tyrosine Kinase Inhibitors in lung cancer patients. <br/ ><br>Timepoint: 3 years